 |
Ventracor Limited Company Summary |
 Ventracor is a global medical device company which produces an implantable blood pump, the VentrAssist left ventricular assist device (LVAD), as a therapy to improve the lives of heart failure patients. Ventracor is dedicated to building partnerships with healthcare professionals to make the VentrAssist the standard-of-care worldwide.
|
|
 |
COMPANY DATA |
 |
Headquarters |
126 Greville Street |
 |
| |
|
Chatswood NSW 2067 |
|
| |
|
Australia |
|
|
Telephone |
+61 2 9406 3100 |
|
|
Fax |
+61 2 9406 3101 |
|
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Healthcare |
|
|
Homepage |
www.ventracor.com.au |
|
| |
|
|
MARKETS |
|
|
|
|
|
NEWS |
 |
| |  Ventracor Limited (ASX:VCR) Announce 250th Implant of VentrAssist Left Ventricular Assist Device (LVAD) (MAY 6, 2008) | | Ventracor Limited (ASX:VCR) Announce Results of US Feasibility Trial of the VentraAssist LVAD (APR 14, 2008) | | Ventracor Limited (ASX:VCR) CEO Peter Crosby Letter to Shareholders (APR 3, 2008) | | Ventracor Limited (ASX:VCR) Announce Election of John Ward to Chairman (APR 3, 2008) | | Ventracor (ASX:VCR) Announce US FDA Unconditional Approval of Destination Therapy Trial For LVAD (MAR 17, 2008) | | Ventracor Limited (ASX:VCR) Appoints Destination Therapy Trial Principal Investigator For LVAD (MAR 13, 2008) | | Ventracor Limited (ASX:VCR) Announces 200th VentraAssist LVAD (Left Ventricular Assist Device) Implant (FEB 11, 2008) | | Ventracor (ASX:VCR) Announces European Approval for New Version VentrAssist LVAD (DEC 19, 2007) | | Ventracor (ASX:VCR) To Use New LVAD In US Clinical Trial Program (DEC 18, 2007) | | Ventracor Limited (ASX: VCR) Announce Milestone with FDA Approval for Heart Pump (DEC 3, 2007) | | Ventracor Limited (ASX: VCR) Letter To Shareholders (NOV 22, 2007) | | Ventracor Growth Continues - 10 Active US Hospitals As Part Of US Clinical Trials (NOV 20, 2007) | | Ventracor (ASX: VCR) Announce 150 VentrAssist Implants Worldwide (OCT 5, 2007) | | Ventracor Announces FY2007 Results And Strong Revenue Growth on 64 LVAD Implants (AUG 16, 2007) | | Ventracor Launch US Pivotal Trial of VentrAssist (JUNE 6, 2007) | | Ventracor; Growing Global Momentum Results in Strong Revenue Growth (JUNE 5, 2007) | | Ventracor's Clinical Trial Programme In US Gaining Traction (MAY 29, 2007) | | Ventracor Appoints New Directors To Strenghten Board (MAY 2, 2007) | | Ventracor Limited Investor Update March 2007 (MAR 29, 2007) |
|
|
